The stock of commercial-stage biotech Travere Therapeutics ( TVTX +13.91%) barreled into the late holiday period in style. On a pair of new analyst notes covering the company, investors piled into its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback